Jodi Maiolo, MPH, CPH, and Shanen Wright will discuss a campaign to reduce stigma in Appalachia that they worked on and how some of their takeaways can be used to create more effective messaging in other communities.
Stigma, lack of coverage and inadequate training for physicians are creating barriers to treatment for SUD, but digital therapeutics are emerging as an effective complement to boost traditional treatment, according to Smita Das, MD, PhD, MPH, and Mario San Bartolome, MD, MBA, MRO, FASAM.
The lifetime prevalence of a substance use disorder (SUD) hovers around 20% in the general population. The lifetime prevalence of chronic pain is about the same. Rates of both are much higher, however, in the psychiatric patient population.